Viewing Study NCT05128734


Ignite Creation Date: 2025-12-25 @ 2:36 AM
Ignite Modification Date: 2026-03-03 @ 2:04 AM
Study NCT ID: NCT05128734
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-12-15
First Post: 2021-10-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Temozolomide Monotherapy or in Combination With Olaparib in Patients With Triple Negative Breast Cancer (TNBC)
Sponsor: AHS Cancer Control Alberta
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module